Live Breaking News & Updates on Outlook Therapeutics Daily
Stay updated with breaking news from Outlook therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Outlook Therapeutics, Inc. (NASDAQ:OTLK – Free Report) – HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Outlook Therapeutics in a research report issued to clients and investors on Friday, May 17th. HC Wainwright analyst D. Tsao expects that the company will post earnings per share of ($1.00) for the quarter. HC […] ....
HC Wainwright reissued their buy rating on shares of Outlook Therapeutics (NASDAQ:OTLK – Free Report) in a report published on Friday, Benzinga reports. HC Wainwright currently has a $30.00 price target on the stock. HC Wainwright also issued estimates for Outlook Therapeutics’ Q1 2025 earnings at ($1.00) EPS, Q2 2025 earnings at ($0.50) EPS, Q3 […] ....
Comparing Revolution Medicines (NASDAQ:RVMD) & Outlook Therapeutics (NASDAQ:OTLK) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Outlook Therapeutics (NASDAQ:OTLK – Free Report) had its price target upped by HC Wainwright to $30.00 in a research note released on Monday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Outlook Therapeutics’ Q2 2024 earnings at ($0.95) EPS, Q3 2024 earnings at ($1.09) […] ....
Outlook Therapeutics (NASDAQ:OTLK) Price Target Raised to $30.00 at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.